Abbott Laboratories - 35 Year Stock Price History | ABT

Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Abbott Laboratories as of November 19, 2018 is 70.54.
Abbott Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 63.2082 57.9762 74.1200 55.7546 70.5400 25.34%
2017 47.4997 37.6421 56.6744 37.6421 56.2800 52.00%
2016 38.6495 40.3639 43.3818 34.3884 37.0251 -12.32%
2015 43.1634 41.3317 47.8589 36.5111 42.2255 1.89%
2014 37.3928 34.4215 42.6848 32.4602 41.4421 20.08%
2013 31.9015 28.3980 34.8537 28.3980 34.5116 23.75%
2012 26.5688 23.7775 30.7100 22.7945 27.8872 18.31%
2011 21.2605 19.6943 23.6140 18.6813 23.5721 19.46%
2010 20.7542 22.0757 22.8763 18.7295 19.7314 -9.84%
2009 19.5067 21.3712 22.9224 16.6961 21.8851 2.77%
2008 21.8949 21.9949 23.9047 19.7313 21.2954 -3.77%
2007 21.3497 19.0808 23.2851 19.0808 22.1289 16.59%
2006 17.4602 15.2139 19.2210 15.2139 18.9795 25.13%
2005 17.3683 17.7512 19.1169 14.4753 15.1677 -14.52%
2004 15.6873 16.4456 17.8729 13.8767 17.7436 8.24%
2003 14.4605 13.9401 16.5863 11.9986 16.3928 17.74%
2002 15.8908 19.2507 19.9255 10.7619 13.9227 -27.56%
2001 17.2106 16.4658 19.5713 14.4180 19.2196 15.98%
2000 14.2275 11.8783 19.0726 10.0783 16.5718 34.48%
1999 14.7626 16.4351 17.8985 11.3047 12.3229 -25.40%
1998 13.7622 11.3133 16.7722 11.1875 16.5194 50.34%
1997 10.3218 8.4085 11.5130 8.4085 10.9879 29.72%
1996 7.5467 6.9350 9.4717 6.4438 8.4703 22.49%
1995 6.3804 5.3927 7.4045 5.1716 6.9150 28.23%
1994 4.8930 4.7458 5.5580 4.2994 5.3927 10.75%
1993 4.4008 4.9637 4.9637 3.7741 4.8691 -1.91%
1992 5.0069 5.4759 5.5468 4.4012 4.9637 -11.49%
1991 4.2366 3.5139 5.6078 3.2314 5.6078 53.39%
1990 3.0953 2.8081 3.6967 2.5554 3.6560 32.59%
1989 2.3948 1.9337 2.8438 1.8890 2.7574 41.47%
1988 1.8956 1.9666 2.1035 1.7401 1.9491 -0.11%
1987 2.3247 1.9196 2.7034 1.7389 1.9513 5.82%
1986 1.7726 1.3729 2.1961 1.2873 1.8440 33.58%
1985 1.1005 0.8197 1.4160 0.8072 1.3804 63.88%
1984 0.8661 0.9273 0.9682 0.7667 0.8423 -7.66%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $123.892B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.046B 18.71
Stryker (SYK) United States $62.759B 23.66
Boston Scientific (BSX) United States $48.834B 24.68
Baxter (BAX) United States $34.600B 22.34
Zimmer Biomet Holdings (ZBH) United States $23.151B 15.01
Smith & Nephew SNATS (SNN) United Kingdom $15.845B 0.00
ResMed (RMD) United States $14.616B 27.87
Perrigo (PRGO) Ireland $8.530B 12.95
Bio-Rad Laboratories (BIO) United States $8.041B 51.42
Canopy Growth (CGC) Canada $7.608B 0.00
Hill-Rom Holdings (HRC) United States $6.079B 19.27
Aurora Cannabis (ACB) Canada $5.873B 32.05
Haemonetics (HAE) United States $5.316B 46.75
ICU Medical (ICUI) United States $4.835B 26.94
Insulet (PODD) United States $4.492B 0.00
Hutchison China MediTech (HCM) China $4.108B 0.00
Agios Pharmaceuticals (AGIO) United States $3.867B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.782B 0.00
Neogen (NEOG) United States $3.211B 48.63
NuVasive (NUVA) United States $3.153B 29.33
National Vision Holdings (EYE) United States $2.871B 55.54
Quidel (QDEL) United States $2.378B 31.00
Aphria (APHA) $2.260B 0.00
NxStage Medical (NXTM) United States $1.935B 0.00
Phibro Animal Health (PAHC) United States $1.371B 19.41
AtriCure (ATRC) United States $1.182B 0.00
Cardiovascular Systems (CSII) United States $0.999B 1439.50
VAREX IMAGING (VREX) United States $0.974B 19.57
Meridian Bioscience (VIVO) United States $0.833B 26.55
OraSure Technologies (OSUR) United States $0.761B 42.86
Surmodics (SRDX) United States $0.759B 115.98
Eagle Pharmaceuticals (EGRX) United States $0.737B 23.64
MacroGenics (MGNX) United States $0.713B 0.00
PetIQ (PETQ) United States $0.704B 20.01
Cerus (CERS) United States $0.692B 0.00
Lantheus Holdings (LNTH) United States $0.627B 19.41
Omeros (OMER) United States $0.617B 0.00
Owens & Minor (OMI) United States $0.546B 6.18
LeMaitre Vascular (LMAT) United States $0.537B 26.39
NanoString Technologies (NSTG) United States $0.509B 0.00
Insys Therapeutics (INSY) United States $0.499B 0.00
TG Therapeutics (TGTX) United States $0.428B 0.00
Evolus (EOLS) United States $0.377B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.342B 22.12
Cytosorbents (CTSO) United States $0.316B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.258B 0.00
Surface Oncology (SURF) United States $0.230B 0.00
Rockwell Medical (RMTI) United States $0.205B 0.00
Bovie Medical (BVX) United States $0.193B 0.00
BioLife Solutions (BLFS) United States $0.186B 250.75
Chimerix (CMRX) United States $0.168B 0.00
Fonar (FONR) United States $0.141B 7.07
Conatus Pharmaceuticals (CNAT) United States $0.136B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.116B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
United-Guardian (UG) United States $0.080B 16.68
Female Health (VERU) United States $0.074B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.072B 0.00
InfuSystems Holdings (INFU) United States $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.059B 18.87
CAS Medical Systems (CASM) United States $0.051B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Myomo (MYO) United States $0.023B 0.00
Akers Biosciences Inc (AKER) United States $0.022B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.017B 0.00
Senestech (SNES) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00